Josef Kroupa: Landmark PRAGUE-26 Trial Advances Interventional PE Treatment
Josef Kroupa, Interventional Cardiologist, Healthcare Consultant, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The New England Journal of Medicine, adding:
“Czech cardiology at the forefront.
Today, at the Congress of the European Society of Cardiology, we presented to the international cardiovascular community the results of the largest randomized trial to date investigating interventional treatment of acute pulmonary embolism (PRAGUE-26).
At the same time, its results are being published in The New England Journal of Medicine (NEJM) — marking the first original Czech study in history to be published in the journal.
Behind this study are years of hard work, an extraordinary team effort, and above all, a shared ambition to change the way this serious disease is treated worldwide.
A heartfelt thank you to everyone who has been part of this journey.
And yes — we did it!”
Title: Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
Authors: Josef Kroupa, Martin Radvan, Jan Mrozek, Martin Sluka, Stepan Jirous, Ota Hlinomaz, Milan Pliva, Jan Pudil, Hana Voberkova, Karolina Bartoskova, Martin Poloczek, Martin Kamenik, Michal Brabec, Eva Lichnerova, Martin Hutyra, Ivo Bernat, Martin Novak, Johana Horakova, Lucie Jelinkova, Tomas Knize, Petr Tousek, Cyril Stechovsky, Filip Varhanik, Zdenek Coufal, Jiri Jarkovsky, Viktor Kocka
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 15:20Sohail Khan: What Comes After IV Thrombolysis
-
Sep 1, 2026, 15:09Harish Chowdary Gorrepati: The HALT Paradox After TAV
-
Sep 1, 2026, 14:34Marcin Kurzyna: New NEJM Trial Evaluates Catheter-Directed Thrombolysis in PE
-
Sep 1, 2026, 14:18Rafael Gomes: CoCAP Study Challenges Prolonged DAPT After CABG
-
Sep 1, 2026, 09:16Nicolas Gendron: Real-World Data on Danaparoid in Patients with Suspected HIT
-
Sep 1, 2026, 08:24Cristina Chang: The Importance of The New ET Treatments
-
Sep 1, 2026, 07:22Abdul Mannan: ASH 2026 Guidelines – New Treatment Approach for Adult ITP
-
Sep 1, 2026, 07:20Alejandro González Veliz: Silent Atherosclerosis Starts Earlier Than We Think
-
Sep 1, 2026, 07:18Alan Nurden: A New Mechanism Behind Immune Thrombocytopenia